Meet the 10 startups in Techstars' first DC healthcare accelerator
Dec 8, 2025
Read Article →Virtual Care Provider for Precision Medicine
The convergence of medical wearables, digital twins, agentic AI, and clinical care to transform precision care delivery.
Coming Soon: CIPRA Medical Wearable
Why CIPRA
Better outcomes require precision and prediction.
Traditional care is reactive and one-size-fits-all. CIPRA identifies the highest-impact interventions for every patient, predicts health risks before they become clinical events, and optimizes the right balance of AI and clinical expertise to improve engagement and outcomes at scale.
Precision That Drives Action
A digital twin pinpoints each patient's highest-impact interventions.
True Prevention Requires Prediction
AI forecasts emerging risks and triggers personalized care while there’s still time.
The Right Care, at the Right Time
Our Clinical Physical AI orchestrates AI health agents and clinician action so every patient gets the right care at the right moment.
Who we serve
One intelligent care program. Supporting every part of healthcare.
Patients
Daily guidance built around your own numbers, with a care team behind it.
For patients →Providers
Between-visit chronic care your practice can offer without adding staff.
For providers →ACOs
Close quality gaps and control total cost across attributed lives.
For ACOs →ACCESS
Purpose-built support for the CMS ACCESS model.
For ACCESS →Payors & TPAs
One AI platform for prevention, chronic care, and enablement.
For payors & TPAs →
Clinical evidence
Validated through clinical research and live healthcare deployments.
85%+
Weekly engagement
Patients actively taking readings and completing check-ins, week after week.
3×
Improvement in control rates
Patients are more likely to achieve and sustain control than with usual care.
40×
Reduction in clinical workload
AI-powered care automates routine monitoring and outreach, dramatically reducing the work required per patient.
Testimonials
Patient Success Stories
Parish J
55 yrs old
Even without human health coaches, Parish felt like he
had a dedicated team of mentors by his side to help manage his blood
pressure.
Pauly K
61 yrs old
Pauly experienced 27 years of chronic high blood
pressure, but with CIPRA.ai, adopted lifestyle changes to effectively
manage her condition.
David K
85 yrs old
David credits CIPRA.ai’s disciplined monitoring
and insights for his dramatic blood pressure improvement from 150/80 to
115/68 in five months.
Partners
Trusted where care actually gets delivered.
Healthcare Partners
Durga Madala Cardiology
Blossom Ridge Medical Group
Innovation & technology partners
In the news
What we've been up to.
See what this looks like for your population.
Our Approach
How CIPRA Delivers Precision Predictive Care
CIPRA brings together continuous sensing, patient-specific intelligence, AI health agents, and clinical expertise to continuously understand each patient, predict what comes next, and deliver the right care at the right time.
Every signal that matters.
CIPRA brings together physiological, behavioral, nutritional, and patient-reported data to create a continuous, multidimensional view of each patient’s health.
Health Signals
- Blood Pressure — Connected BP monitors and longitudinal BP patterns
- Glucose — Glucometers and CGMs
- Heart Health — Holter and other cardiac monitoring
- Activity & Movement — Steps, exercise, motion, and activity patterns
- Sleep & Recovery — Sleep duration, patterns, and recovery signals
- Nutrition — Meals, nutrients, dietary patterns, and nutrition behaviors
- Medications — Medication schedules, adherence, and patient-reported use
- Patient-Reported Data — Symptoms, questionnaires, goals, and preferences
- Context & Behavior — Daily routines, lifestyle patterns, engagement, and other contextual factors
- EHR — Lab results, clinical history, and diagnostic data from your EHR
Purpose-built sensing, not a fitness tracker.
Unlike consumer wearables, CIPRA’s medical wearable is built for AI-driven precision care. Guided by each patient’s digital twin, it delivers personalized health measurements while continuously enriching the digital twin with real-time physiological data—without a third-party intermediary.
Highlights
- Continuous blood pressure monitoring — no manual cuff required
- Passive data collection for effortless adherence and a better patient experience
- Enhanced motion and activity analysis
- Heart health, sleep, and stress monitoring
- Continuously enriches the patient’s digital twin with personalized physiological data
- Direct access to raw sensor data, without a third-party intermediary
Every Patient Deserves Their Own Digital Twin
CIPRA’s digital twin creates a patient-specific understanding of health that enables precision care and predictive intelligence. It identifies the key drivers of each patient’s condition, forecasts emerging health risks, and determines which interventions are most likely to make a difference.
Highlights
- Patient-specific precision — understands what matters most for each patient
- Predictive health intelligence — forecasts emerging risks before they become clinical events
- Personalized interventions — identifies actions most likely to improve outcomes
- Continuous learning — evolves with each patient’s health and behavior
AI Agents That Deliver Continuous Care
CIPRA’s AI health agents continuously engage patients, monitor progress, answer questions, and deliver personalized actions. They extend the reach of clinical teams, providing individualized support at scale while escalating patients who need human care.
Highlights
- Personalized guidance and interventions
- Proactive patient engagement
- Continuous monitoring and follow-up
- Intelligent escalation to clinicians
- Personalized care at population scale
Expert Clinicians, Amplified by AI
CIPRA’s experienced clinical team of nurses and clinicians delivers personalized care throughout each patient’s journey. AI health agents continuously monitor patients, provide routine guidance, and surface prioritized insights—allowing clinicians to focus on higher-risk patients, complex decisions, and meaningful patient interactions.
Highlights
- Experienced clinical team of nurses and clinicians
- Continuous AI monitoring and personalized patient guidance
- Intelligent prioritization of patients needing clinical attention
- More time for high-value, patient-centered care
Optimizing Patient–Clinician–AI Collaboration
Physical AI has been built to sense and act on the world through motors. We built it to sense and act on the world through people. CIPRA’s Clinical Physical AI creates a continuous learning system for healthcare—observing patient health, adherence, engagement, and care delivery, then orchestrating personalized actions through AI health agents and clinicians. Each action generates new insight, continuously improving engagement, outcomes, utilization, and precision care. AI Agent decisions are grounded in real physiological data and checked by deterministic safety rules before they reach a patient or clinician, with real risk escalated to a licensed clinician.
Highlights
- Observe patient health, adherence, engagement, and care delivery in real time
- Orchestrate personalized actions for AI health agents and clinicians
- Optimize engagement, outcomes, clinical utilization, and operational efficiency
- Continuously improve care delivery through an intelligent feedback loop
- Deterministic safety guardrails filter every AI decision before it reaches a patient or clinician
See what this looks like for your population.
For Patients
Care that keeps up with your life.
CIPRA gives you daily guidance built from your digital twin — and a real care team watching, so nothing gets missed between appointments.
The challenge
Managing a chronic condition shouldn’t be a full-time job.
Tracking symptoms, remembering medications, wondering if a number is normal, chasing down the next appointment — that’s a second job most patients never signed up for. CIPRA takes that job off your plate, quietly, in the background. We carry the burden of managing your condition, so you can just focus on living your life.
We watch, so you don’t have to worry
No need to interpret your own numbers or wonder if something’s wrong — a nurse is already reviewing every reading, quietly in the background, ready to step in the moment it matters.
We remember, so you don’t have to
Medications, follow-ups, monthly assessments — tracked and handled for you, built around your own digital twin. A quick daily check-in is all it takes; everything else happens automatically.
We’re there, so you’re never carrying it alone
Real-time follow-up between visits means nothing waits until your next appointment. Go to work, see your family, live your life — knowing it’s already being looked after.
What CIPRA delivers
What you get.
A reliable device, delivered to your door
FDA-cleared, easy to use out of the box — no setup, no fees, no trip to a store.
Readings that reach your care team
Every reading goes straight to your CIPRA nurse, so your provider always has the full picture.
A nurse who knows you
Real-time response when something needs attention, plus monthly check-ins and assessments to keep your plan on track.
Your digital twin, in your pocket
The CIPRA app with Alma, your AI health companion, and NutriLab — see exactly how your body responds to food, sleep and activity.
The CIPRA app
Meet your digital twin and Alma.
Your digital twin learns from your health data, behaviors, and interactions to build a personalized understanding of you and what influences your health. Alma is your 24/7 AI care team member, using that understanding to answer your questions, provide personalized guidance, help you stay on track, and connect you with your CIPRA clinical team when needed.
Personalized Guidance, Every Day
AI That Knows Your Care
AI-Powered Meal Understanding
Predictive Insights Before You Eat
One View Of Your Health
Personalized Guidance, Every Day
AI That Knows Your Care
AI-Powered Meal Understanding
Predictive Insights Before You Eat
One View Of Your Health
For Providers
Chronic care between visits, without adding burden.
CIPRA runs the program — enrollment, devices, monitoring and documentation — so you can scale easily, keep patients engaged and loyal, and see a proven return backed by real patient outcomes. Your clinicians stay in control of every clinical decision.
Scale programs easily
Up and running in weeks, not months.
Keep patients engaged
Patients stay loyal to the provider who cares.
Proven patient outcomes
We have the data to show how we positively impact patient lives.
Get your ROI
Low cost, low lift, and dependable recurring revenue.
Why CIPRA
More than a platform — a true clinical partner, built to hit whatever you’re measured on.
Our programs make your practice more comprehensive and attentive — supplemental to what you already do, building the kind of loyalty patients don’t shop away from. Whatever your scorecard is — MIPS, HEDIS, Star ratings, value-based contracts — CIPRA is built around the levers that move it, powered by a digital twin for every patient, not just a monitoring dashboard.
Build patient loyalty
Consistent attention between visits builds trust — patients who feel looked after don’t shop around.
A digital twin for every patient
Root causes identified, a precise care pathway built, hyper-personalized guidance delivered — automatically, for every patient.
Better metrics, more credibility
Consistent monitoring and follow-up translate directly into stronger quality scores you can prove.
Accessible, low-cost, AI-guided
No upfront cost, no added cost to patients — licensed clinicians guided by AI, across every program we run together.
What we offer
Choose the program built for your practice.
Whatever your clinic, health system or FQHC is after — HEDIS and MIPS measures, VBC or risk-based contracts, revenue generation, or reaching a rural or diverse patient population — this is where CIPRA fits in.
What is RPM
Remote Patient Monitoring, designed for your clinic.
A CMS-reimbursed service where connected devices track patient vitals between visits, and a licensed clinician reviews the data and steps in when something looks off.
The problem, solved
Everything that gets in the way, handled.
Staffing, device logistics, and gaps between visits are what keep most practices from running a program like this well. CIPRA takes each one off your plate — and uses the technology to catch problems before they become a crisis.
Staffing
Round-the-clock monitoring shouldn’t mean hiring a new team. CIPRA’s clinicians are the extension of yours.
Device logistics
Sourcing, shipping, setup and support — handled directly with the patient, so your staff never touches inventory.
Patient care gaps
Continuous monitoring closes the gaps between visits — reducing hospital readmissions, improving medication adherence, and catching concerning trends before they become a crisis.
One-of-a-kind AI
Our technology builds a precise, individual picture of every patient — whether it be a glycemic response predictor, or personalized nutrition, activity and sleep recommendations — meeting patients where they are to drive high engagement and real, measurable results.
What CIPRA delivers
A turnkey RPM program.
We enroll your patients
Eligibility review, consent calls and referral.
We manage devices directly to patients
Ready-to-use devices sent directly to your patient’s door, with setup help included.
We monitor
Licensed clinicians review readings, trends, engagement and gaps in care daily, escalating to you only when needed.
We handle documentation
A monthly activity and billing report, aligned to CMS guidelines.
How it works
Go live in 2 weeks.
01
Patient referral
We review your panel and identify patients who could benefit from remote monitoring.
02
Kickoff call
We confirm your go-live date, the referral process and clinic marketing together.
03
Go-live
We contact your patients, gain consent and enroll them on your behalf.
04
Ongoing care & billing
A dedicated care manager oversees every patient. We handle it end to end, and provide you with compliant documentation and billing.
2026 RPM billing codes
A new, sustainable revenue stream for your practice.
99453 · ~$22
One-time per device. Covers initial setup and patient education on how to use the equipment.
99445 or 99454 · ~$52
Device supply and data transmission — 99445 for 2–15 days of readings, 99454 for 16+ days. Bill one, not both, per 30-day period.
99470 · ~$26
First 10–19 minutes of clinical time in the month, with at least one live interactive check-in with the patient or caregiver.
99457 · ~$52
First 20 minutes of clinical time in the month, with at least one live interactive check-in. Bill 99470 or 99457, not both.
99458 · ~$41
Each additional 20 minutes of clinical time beyond 99457, up to 2 units per month.
Figures are 2026 Medicare national average rates and vary by locality. Learn more about Remote Patient Monitoring CPT codes →
Proof
What partners see in practice.
85%+
Weekly engagement
Patients actively taking readings and completing check-ins, week after week.
15 mmHg
Average BP improvement
Systolic reduction driven by sustained, high-adherence monitoring.
2.0 pts
Average HbA1c improvement
Meaningful glycemic control gains across the CIPRA population.
90%+
CPT code utilization
Reimbursable time and services captured, month after month.
What is CCM
The care your patients deserve, that we’re experts in facilitating.
CCM is a CMS-reimbursed service for patients with two or more chronic conditions — ongoing coordination and care-plan management between visits, run by a dedicated team. We identify eligible patients across your panel and manage the entire program end to end.
Conditions go uncoded
A myriad of CCM-eligible conditions go unmanaged and uncoded in most panels.
Coordination gaps
Specialists, primary care and the patient rarely stay in sync between visits.
No office bandwidth
Monthly outreach and documentation for every complex patient takes a dedicated team.
An array of conditions covered
A broad range of chronic conditions.
More than a platform
A trusted, world-class clinical team.
CIPRA is a true partner and extension of your clinic — not just software. The value is in the organization behind it: our technology matched with our clinical team, AI optimization tuned continuously for better results, for the patient, for your practice, and for how fully the program gets used.
How it works
How we identify and enroll your patients.
01
Identify eligible patients
We review your panel and help identify patients with two or more chronic conditions.
02
Outreach & enrollment
We reach out to enroll patients and build care plans from the care pathway the provider already created — then make sure it’s actually followed.
03
Monthly review cycle
Disease-specific goals and recommendations, then medication, lifestyle, SDOH and mental health reviews, in sequence, every 6 months.
04
Escalate when needed
Only the cases that need provider input or additional support are routed to your clinic — everything else, we handle.
The assessment cycle
A structured review, every month.
Each patient moves through a focused monthly check-in — then the cycle repeats every 6 months, keeping care current as conditions change.
Month 1 · Baseline
Full assessment, medication reconciliation, personalized care plan.
Month 2 · Medication
Adherence, side effects, refill needs.
Month 3 · Lifestyle
Nutrition, exercise, sleep, tobacco and alcohol use.
Month 4 · SDOH
Transportation, food and housing security, financial barriers.
Month 5 · Mental health
PHQ and GAD screening, referred out when indicated.
Month 6 · Disease-specific
Condition status, symptom progression, plan adjustments.
Month 7 · Reassessment
Everything is repeated and updated, resetting the 6-month cycle.
Presenting this to your provider
What it means for your practice.
- Minimal lift from your office — CIPRA runs enrollment, monitoring and documentation.
- High patient satisfaction, with a dedicated care team patients get to know and trust.
- Improved patient outcomes, backed by continuous, data-driven care between visits.
- High program integrity, with every interaction documented and defensible.
- Full alignment and compliance with CMS guidelines.
2026 CCM billing codes
A sustainable, CMS-reimbursed revenue stream.
99490 · ~$66
First 20 minutes of non-complex CCM services in the month, provided by clinical staff under general supervision.
99439 · ~$50
Each additional 20 minutes of non-complex CCM services beyond 99490, up to 2 units per month.
99487 · ~$144
First 60 minutes of complex CCM services in the month, requiring moderate or high complexity medical decision-making.
99489 · ~$78
Each additional 30 minutes of complex CCM services beyond 99487.
Figures are 2026 Medicare national average rates and vary by locality. Learn more about Chronic Care Management CPT codes →
Proof
What partners see in practice.
85%+
Weekly engagement
Patients actively taking readings and completing check-ins, week after week.
15 mmHg
Average BP improvement
Systolic reduction driven by sustained, high-adherence monitoring.
2.0 pts
Average HbA1c improvement
Meaningful glycemic control gains across the CIPRA population.
90%+
CPT code utilization
Reimbursable time and services captured, month after month.
Already running CCM? You’re even more closely aligned with ACCESS.
The chronic-condition management CIPRA already runs under CCM overlaps directly with what CMS’s ACCESS model asks for — ongoing coordination, monitoring and documentation for patients with cardio-kidney-metabolic and related conditions. If your organization is evaluating ACCESS participation, CCM is a head start.
What CIPRA delivers
Low cost. Real outcomes. Proven with our partners.
CIPRA gives health systems a low-cost way to step into value-based care and drive outcomes that hold up to scrutiny — already proven with our partners. Whether your organization is seasoned in risk-based contracts or just getting started, we know how to implement the program that actually keeps patients engaged and adherent.
Low cost to deploy
No infrastructure to build and no new hires — CIPRA runs the program end to end.
Real patient outcomes
Measurable improvement in condition control, not just engagement metrics.
Already proven
Results already demonstrated with our partners, not just promised.
Built for any stage
Whether your health system is seasoned in VBC or just stepping in, we tailor the program to where you are.
The autonomous digital twin
Technology that keeps patients engaged and adherent, on its own.
Every patient gets an autonomous digital twin built from their own data — connected to their wearables, continuously learning, and always working in the background.
Connected to wearables
Activity, sleep and vitals stream in automatically, so the digital twin stays current without any effort from the patient.
The CIPRA app, powered by their digital twin
Patients see their own digital twin in the CIPRA app — real insight into their lifestyle, with personalized recommendations to match.
Built for adherence
The digital twin is what keeps patients engaged and adherent, long after enrollment.
Panel-wide coverage
Every eligible patient gets a digital twin, not just the ones already engaged.
How it works
Patient care and guidance, handled autonomously.
CIPRA’s AI agents run the day-to-day of the program on their own — CIPRA is the platform, devices and support behind your VBC program, while your clinical team stays in control of every clinical decision.
Autonomous onboarding
Patients register in the CIPRA app, devices ship directly to their door, and our agents handle education and setup — no lift for your team.
Autonomous engagement
AI agents collect data continuously and deliver precise, hyper-personalized guidance — adherence check-ins, medication reminders and patient queries, all handled without a human care manager in the loop.
Insights shared your way
What you see is customizable to what you’re trying to track or improve — whether it’s hypertension, diabetes, cardiovascular risk, musculoskeletal pain, or whatever matters most to your program.
Proof
What partners see in practice.
85%+
Weekly engagement
Patients actively taking readings and completing check-ins, week after week.
3×
Improvement in control rates
Patients are more likely to achieve and sustain control than with usual care.
40×
Reduction in clinical workload
AI-powered care automates routine monitoring and outreach, dramatically reducing the work required per patient.
4×
ROI from medical savings
Lower healthcare costs driven by better chronic disease control and fewer costly events.
See what a program would look like in your practice.
For ACOs
Close gaps and control cost across attributed lives.
CIPRA extends chronic care management across your attributed population without adding staff to any single practice.
Shared savings
How CIPRA drives shared savings across your network.
Lower total cost of care
Digital twins flag deterioration before it becomes an ED visit or admission.
Stronger quality scores
Twin-guided nudges move the exact BP and A1c numbers your contract is scored on.
Accurate acuity, fairer benchmarks
Continuous, patient-owned signal — not an annual visit — sets your risk adjustment.
40× more patients per care team
Clinician-supervised agents handle routine monitoring; your team steps in only when it matters.
Fits your existing analytics stack
Feeds your population health platform raw signal, not a monthly summary file.
Built for complex populations
Multilingual, clinician-supervised engagement for high-need Medicare and Medicaid beneficiaries.
Proof
What partners see in practice.
85%+
Weekly engagement
Patients actively taking readings and completing check-ins, week after week.
3×
Improvement in control rates
Patients are more likely to achieve and sustain control than with usual care.
40×
Reduction in clinical workload
AI-powered care automates routine monitoring and outreach, dramatically reducing the work required per patient.
4×
ROI from medical savings
Lower healthcare costs driven by better chronic disease control and fewer costly events.
Model the opportunity across your attributed lives.
For ACCESS
Purpose-built support for the CMS ACCESS model.
CIPRA supplies the technology and the clinical staffing the ACCESS model requires — ready to deploy from day one.
What is ACCESS
A real shift away from fee-for-service.
ACCESS moves Medicare payment away from paying for activities and toward paying for outcomes — a fresh, performance-based approach that rewards organizations for actually improving patient health, not just delivering a defined set of services. It’s a new way of thinking about healthcare, and it’s deeply aligned with value-based care: the same foundation CIPRA was built on, and where we’ve always been focused.
From activities to outcomes
Payment is tied to whether patients actually improve, not to how many services were delivered along the way.
Built for technology-supported care
ACCESS was designed around exactly the kind of continuous, tech-enabled chronic care CIPRA already delivers.
Where CIPRA already shines
Value-based, outcomes-driven care is our foundation — ACCESS is a natural extension of the model we were built for.
Sourced directly from CMS. Learn more about the ACCESS model on CMS.gov →
Clinical tracks
The ACCESS tracks CIPRA supports.
CMS’s ACCESS model is organized into four clinical tracks. CIPRA runs all four.
eCKM
Early cardio-kidney-metabolic — hypertension, dyslipidemia, obesity/overweight with central adiposity, and prediabetes.
CKM
Cardio-kidney-metabolic — diabetes, chronic kidney disease (stage 3a/3b), and atherosclerotic cardiovascular disease.
MSK
Musculoskeletal — chronic musculoskeletal pain.
BH
Behavioral health — depression and anxiety.
The challenge
New model, real requirements — and how we help you meet them.
ACCESS pays for outcomes, not activities — and that changes what it takes to participate. Here’s what each requirement actually means, and how CIPRA gets you there.
Payment follows outcomes, not visits
Full payment depends on the share of your patients who hit their outcome targets each year, and that bar rises every year you participate. We know how to actually improve clinical outcomes — not just report on them — so your payment stays consistent year after year.
Compliance is non-negotiable
Medicare Part B enrollment, a designated physician Clinical Director, and full HIPAA and FDA compliance are all required from day one. CIPRA supports this with full HIPAA compliance, FDA-cleared devices, and compliant reporting built in from the start.
Reporting runs continuously
Secure, interoperable systems, CMS API integration, and regular progress updates to referring clinicians are ongoing operational work, not a one-time setup. We’re technology experts — this is what our platform is built to handle, day in and day out.
Patients need to engage
Outcome targets only get hit if patients actually stick with the program. Our digital twin and AI-guided care are built specifically to keep patients engaged longer and more consistently than a traditional check-in model.
What CIPRA delivers
We’re the arm that completes it.
The devices, the app, the clinical staff, the knowledge, and the compliance-ready organization to support your ACCESS initiative — all in one partner.
Devices and wearables
Ready to seamlessly integrate into everyday life, ready to use out of the box. Whether a patient already has a wearable or needs one, we support both — pulling data directly from Apple Health, Google Fit and similar platforms.
The CIPRA app
Alma, NutriLab, and daily guidance patients actually use — built on each patient’s digital twin.
Licensed clinical staff
Nurses and care managers who run the program day to day, backed by CIPRA’s clinical knowledge base.
Compliance-ready reporting
Documentation and outcome reporting built around what ACCESS requires, from day one.
2026–2027 ACCESS payment amounts
What each track pays.
ACCESS pays recurring Outcome-Aligned Payments per beneficiary — an Initial Period, and for most tracks, a reduced-rate Follow-On Period for continued support.
eCKM · $360 / $180
$360 per beneficiary in the Initial Period, $180 per beneficiary in the Follow-On Period.
CKM · $420 / $210
$420 per beneficiary in the Initial Period, $210 per beneficiary in the Follow-On Period.
MSK · $180
$180 per beneficiary in the Initial Period. This track has no Follow-On Period.
BH · $180 / $90
$180 per beneficiary in the Initial Period, $90 per beneficiary in the Follow-On Period.
Rural beneficiaries in the eCKM and CKM tracks receive an additional $15 during the Initial Period to help offset connected-device distribution costs. Full payment is tied to meeting outcome targets. See CMS’s full payment and performance target guidance →
Talk to us about your ACCESS launch.
For Payors & TPAs
One AI platform. Every population. Delivered your way.
Every payor has different populations, staffing models, and goals. CIPRA supports members across the continuum — from prevention to chronic disease management — through a single AI-powered platform, delivered by our clinical team or yours.
Why CIPRA
Built for health plans and TPAs.
Reduce Medical Spend
Digital twins flag deterioration before it becomes an ED visit or hospital admission — lower total cost of care without a new utilization program.
Scale Without Adding Headcount
AI agents handle routine monitoring and outreach, so your team — or ours — covers up to 40× more members without new hires.
Personalized Member Experience
Every member gets a digital twin built around their own biometrics, behaviors, and goals — not generic content.
Differentiate Your Plan
A modern, AI-powered benefit that strengthens satisfaction and retention, and gives your plan a story worth telling in a competitive market.
Conditions we manage
The conditions behind your quality measures.
From hypertension and diabetes to heart failure and stroke, CIPRA’s digital twins model the full range of cardiovascular, cardiometabolic, and related conditions driving your HEDIS scores and Star bonus payments — one platform to contract, credential, and reconcile, instead of a separate point solution for each.
Chronic care
Managed Chronic Care
Every member receives a patient-specific digital twin that continuously predicts health risks and personalizes care. AI health agents handle routine outreach and monitoring, escalating to CIPRA’s clinical team — licensed LVNs and RNs — the moment a case needs a clinical judgment call.
Direct, measurable gains on the blood pressure and diabetes control measures behind your HEDIS scores and Star bonus payments.
85%+
Weekly engagement
Patients actively taking readings and completing check-ins, week after week.
3×
Improvement in control rates
Patients are more likely to achieve and sustain control than with usual care.
4×
ROI from medical savings
Lower healthcare costs driven by better chronic disease control and fewer costly events.
Prevention
Managed Prevention
The same AI platform, built for true prevention. Patient-specific digital twins continuously predict health risks and generate personalized preventive actions, while AI health agents engage members before disease develops.
Enablement
Clinical Team Enablement
Already have a care team? Bring CIPRA’s AI platform to them. AI health agents continuously monitor members, prioritize who needs attention, automate routine outreach, and recommend next best actions — allowing clinicians to focus on higher-value care.
Run prevention, chronic care, or your own care management program — all powered by the same AI platform.
Parish J
55 yrs old · Hypertension
Even without human health coaches, Parish felt like he
had a dedicated team of mentors by his side to help manage his blood pressure.
I have been working with the CIPRA.ai program for over six months and I must say it has been a transformative journey. The impact has been nothing short of outstanding.
Before the program, I faced challenges and uncertainties in managing BP effectively. On most days, I had no idea of my blood pressure readings or how different activities were affecting my blood pressure. Since joining the program, I have been provided with invaluable insights, skills, and resources to tackle these challenges head-on.
Although the program is not paired with any human health coaches, it was like having a dedicated team of mentors and experts by my side to help me manage my BP. The program's support has been instrumental in refining my behavior, diet, and activities that affect my blood pressure.
Lynda F
71 yrs old · Hypertension
Lynda said goodbye to one-size-fits-all advice and
discovered consistent blood pressure improvements through our tailored program.
This program is great! Before CIPRA.ai there were several one-size-fits-all recommendations that didn't necessarily make sense for my needs. I would try five things and not be sure what worked if anything. Salt? Stress? Exercise? Diet? Weight loss? I was told I could do everything right, and still have high blood pressure.
With this program I get weekly lifestyle suggestions based on my unique circumstances. I couldn't be happier with the results. My average BP has reduced steadily and I love getting a message that says "your average BP is 5% lower than last week. Nice work!" That's happened more than once.
David C
71 yrs old · Hypertension
David reflects on the lifesaving potential of the
CIPRA.ai program and his personal journey from 140/90 to 125/80.
I am a 71-year-old male and have had hypertension for years and have been taking a couple of medications with different dosages. It was averaging 135/85. Early this year as we came out of the pandemic and I had not exercised regularly for a while. When I joined the CIPRA.ai program in Feb. 2023 my BP was averaging low 140/90. After a short while, the program encouraged me to exercise more. I started doing short swims 3–4 times a week and played golf twice a week, one time riding with a golf cart and the other time walking on regular 18-hole courses. And my BP lowered to 135/85 and inched toward 130/80.
During the hot summer weeks, I overdid it playing golf at courses with 90°F+ temperatures. The CIPRA.ai program immediately noticed that and suggested that I slow down and it really worked. Meanwhile my Fitbit data showed that I had poor sleeping patterns. The CIPRA.ai program encouraged me to get a good solid night's sleep and take a short noon nap if needed. Now my BP is average below 130/82 and often in the 125/80 range. The CIPRA.ai program is a good monitoring program and makes appropriate recommendations based on my BP and Fitbit data.
David K
85 yrs old · Hypertension
From 150/80 to an incredible 115/68 five months later,
David credits CIPRA.ai’s disciplined monitoring and insights for his
dramatic blood pressure improvement.
My BP has improved from typically about 150/80 when I started in February 2023 to an average of 115/68 the first week of August. This is a dramatic reduction. I have changed medications during this time but I think the discipline of recording BP twice a day, together with CIPRA.ai insights and hints have been the biggest driving factor.
Pauly K
61 yrs old · Hypertension
Pauly experienced 27 years of chronic high blood pressure,
but with CIPRA.ai, adopted lifestyle changes to effectively manage her condition.
I have had long term chronic high blood pressure for 27 years and taken Amlodipine 10mg and Metoprolol 25mg daily for the last 7 years, which sometimes kept my BP under control. Often it was between 130/80–150/96 mmHg.
Since I have been with the CIPRA.ai program, I have started meditation and changed my lifestyle to be more present and relaxed with many suggested activities through the program. When my BP is getting high, I will practice breathing and relaxing my blood vessels. My BP will come down at least 10 mmHg.
I have also changed my diet to be more mindful of eating plant-based products, and cut down red meat significantly. I relax more and play with my dogs every day when I feel stressed. For 6 weeks now my BP has been in normal ranges — usually under 120/80 mmHg.
Tom W
73 yrs old · Hypertension
With a history of cancer, consistent high blood pressure
was a concern for Tom. CIPRA.ai highlighted the significance of diet and sleep,
resulting in effective management.
Having a history of cancer, I see various specialists throughout the year, during which my blood pressure is taken at each visit. A few years ago, my primary care physician noticed my pressure during these visits was high and prescribed a low dosage of losartan potassium along with more frequent at-home pressure measurements.
This helped, but my pressure still varied. Since I began participating in the CIPRA.ai program, I've seen, in real time, that for me, diet and especially proper sleep habits are also important in lowering and maintaining my blood pressure.
"CIPRA.ai has helped me to improve my health awareness. The app's recommendations are spot-on, and I truly appreciate its precision and effectiveness."
Vinit Sinha
36 yrs old · Diabetes
CIPRA.ai was easy to navigate and highly satisfying — with
its impressive 90% accuracy, Vinit found it both helpful and highly relevant to
his needs.
CIPRA.ai was easy to navigate, and I was highly satisfied with the experience. The app, with its impressive 90% accuracy, proved to be both helpful and highly relevant to my needs.
Deepa
53 yrs old · Diabetes
CIPRA.ai gave Deepa effective recommendations to help
control her diabetes and guided her in planning a healthier lifestyle.
CIPRA.ai is a user-friendly application that provided me with effective recommendations to help control my diabetes. It also guided me in planning my lifestyle more effectively.
P Chakrapani
49 yrs old · Diabetes
CIPRA.ai helped P Chakrapani plan meals and better control
his diabetes — he strongly recommends the program and praises the cooperative
support team.
"Before CIPRA.ai, I was facing difficulty in managing my diet. The CIPRA.ai application helped me plan my meals and better control my diabetes. Due to this, I strongly recommend the program, and the customer support team is very cooperative."
CIPRA.ai uses AI-driven personalised health recommendations to manage chronic conditions, integrating data from wearables for precise, proactive care.
Ready to see results like these in your own program?
About Us
Your Partner for Innovation
Born from six years of R&D and clinical validation at UC San Diego.
The journey
How CIPRA.ai started.
CIPRA.ai is the accumulation of six years of R&D and clinical trials at UC San Diego — supported by Kaiser Permanente, UC San Diego Population Health, Altman Clinical Translational Research Institute, Samsung, Teradata and other industry leaders — which focused on using AI to precisely diagnose and treat patients with chronic conditions.
The impetus for this work came from founder Sujit Dey, after a series of self-experiments determined that sleep was the greatest contributor to his hypertension. These findings motivated Sujit to develop a data-driven, intelligent solution to untangle the complex relationships between lifestyle and chronic conditions, joined by former PhD students and co-founders Jared Leitner and Po-Han Chiang. Assembling a distinguished team of physicians and experts, the company launched in July 2022 and has expanded its AI-based platform to cover chronic cardiovascular and cardiometabolic diseases, with supervision provided by CIPRA.ai’s own expert clinical team as well as its partner health systems.
At the core of CIPRA.ai is our understanding that healthcare is not a one-size-fits-all solution. We understand how disorienting managing chronic conditions can be on your own — a series of trial and error, or varying opinions from different people.
Our mission: to empower care organizations to guide every patient with precision and continuity, so chronic disease becomes manageable rather than a life sentence, and no one faces it alone.
Get to know us
Our Leadership Team
Sujit Dey
Founder, Leads CIPRA.ai
Sujit Dey is a technology visionary and entrepreneur, who has successfully transitioned impactful technologies from research to global deployments. He has founded or co-founded multiple companies in various industry verticals, including wireless, multimedia, renewable energy, and healthcare, leading to multiple acquisitions. He holds the Jacobs Family Endowed Chair in Management and Engineering Leadership at UC San Diego. In 2015, he started the UCSD Connected Health Program, in partnership with healthcare providers and healthtech companies, creating innovative AI based platforms and solutions in multiple healthcare practices. Sujit brings his vast experiences from his previous roles as CEO and CTO in product development and market strategy, partnership and business development, and venture funding and acquisitions to lead CIPRA.ai.
Jared Leitner
Co-founder, Leads Product Engineering & Delivery
Jared Leitner leads product engineering and delivery at CIPRA.ai, overseeing the development and deployment of AI-driven digital health products. Prior to CIPRA.ai, he was a healthcare AI researcher at the University of California, San Diego, where he earned his PhD focused on AI techniques for precision healthcare. He brings end-to-end experience across machine learning, data science, software and cloud engineering, EHR integration, remote patient monitoring, wearable devices, and digital health product delivery.
Po-Han Chiang
Co-founder, Leads Research & Development
PoHan Chiang leads research and development functions at CIPRA.ai. He received his Ph.D. in Electrical and Computer Engineering from the University of California, San Diego in 2022, where he worked with Professor Sujit Dey at the Mobile Systems Design Lab. PoHan has years of experience in digital health technology development, clinical trials and product delivery. PoHan’s research interests include machine learning, digital health, renewable energy powered green communication and industrial Internet of Things (IoTs).
Sasha Lillion
Leads Healthcare Operations
Sasha Lillion is a healthcare operations executive with extensive experience building and scaling value-based care models and digital health programs across diverse care settings. With a background spanning healthcare technology and care management organizations, Sasha specializes in translating complex clinical and technology-enabled programs into scalable, audit-ready operations that providers and health systems can adopt with confidence. She is known for bridging strategy and execution — working across clinical, product, and commercial teams to ensure programs perform consistently at scale. Sasha holds an MBA from the University of Florida and brings to CIPRA.ai a disciplined, execution-focused approach to healthcare operations.
Subasis Bose
Leads Finance and India Operations
Subasis Bose is the head of operations in India at CIPRA.ai, with a career that has spanned across organizations such as Tata NYK, HP, and Netflix. With an extensive background in financial management and operational excellence, Subasis has been a driving force behind major initiatives, leveraging his financial acumen to optimize processes and maximize profitability. Subasis has led global teams across APAC, Europe and Latin America.
Dr. Brian Khan
Leads Clinical Engagement
Brian Khan is a physician and informaticist who works at the intersection of healthcare and technology. Dr. Khan is board-certified in internal medicine experienced in the clinical care of patients with chronic conditions. He is also board-certified in lifestyle medicine which focuses on applying evidence-based, whole-person, prescriptive lifestyle changes to treat and reverse chronic conditions. Brian obtained his MBA in healthcare management and has worked at large health systems like UCSD Health and Adventist Health as a physician leader with broad responsibility around clinical information systems and innovation. Most recently, he has served as the Medical Director of Digital Health and Wellbeing at Advent Health. He is a digital health reviewer for the National Science Foundation and has hands-on experience guiding numerous early growth companies in digital health and AI. He is experienced with clinical trials particularly around the application of technology in healthcare and has numerous journal and textbook publications.
Sumeet Maniar
Leads Partnerships Development
Sumeet Maniar has been a serial entrepreneur, with core expertise in product and new business development where he has led 15+ products and deals totaling $100mm cumulatively. Sumeet’s last several years in the healthcare space is in digital health and AI as CEO of WellBrain. Some relevant successes include driving medical device sales by up to 600% on a practice by practice basis nationwide, thus impacting a $25B industry. Sumeet also has leveraged success in areas of remote patient management and related areas in working with physicians and hospital systems, demonstrating health care savings, Rx decreases, and better patient outcomes. He recently won a product of the year award in Health 2.0 in 2022.
Michael Loewenstern
Leads Business Development and Sales
Michael Loewenstern brings more than 25 years of experience in healthcare sales, business development, and strategic growth. His career has centered on helping healthcare organizations identify opportunities, adopt innovative solutions, and achieve meaningful business results through strong relationships and consultative selling.
Most recently serving as a Sales Director in Digital Health, Michael led SaaS sales and business development initiatives, working with healthcare organizations and executive stakeholders in an evolving technology landscape. His entrepreneurial approach, combined with deep healthcare industry experience, enables him to bridge the gap between technology, business strategy, and the practical needs of healthcare organizations.
A graduate of the University of Delaware, Michael is passionate about building relationships, creating new opportunities, and contributing to innovative approaches that can positively impact healthcare. Outside of work, he enjoys spending time with his two children and family.
Sharmila Chatterjee
Lead Diabetes Dietitian Advisor
Sharmila Chatterjee MSc, MS, RDN, LDN, LD, CDCES, is a US board certified Registered Dietitian and Certified Diabetes Care and Education Specialist with over 25 years of experience in diabetes care in the US, and prior to that in India for 5 years at a diabetes clinic. Sharmila has worked at many health systems across the United States, including Sharp Grossmont Hospital, UCSD Medical Center in San Diego, CA, Endeavor Health in the division of endocrinology, Skokie, IL, and recently joined the University of Texas (UT) Health Houston, UT Physicians, McGovern Medical School in Houston, TX. She has extensive experience and knowledge in the use of technology and devices like insulin pumps, CGMs and InPen, and in the clinical management of Type 1, Type 2 and Gestational diabetes. She is a certified insulin pump trainer (CPT) as well, and is the founder of Global Dietitian Consultant.
Antoripa Dey
Communications Lead
Antoripa Dey leads the communications functions at CIPRA.ai. She earned her B.A.s from New York University in Journalism and Urban Studies, with a concentration in City/Urban, Community and Regional Planning in 2020. Antoripa has years of experience in communications development and management, from notable magazine publications to global nonprofit organizations. At CIPRA.ai, she specializes in fusing internal and external communications through patient and clinician engagement.
Clinical team
Clinical Leadership
Heisy Fajardo, RN
Registered Nurse · Lead Chronic Care Management Nurse
Heisy’s passion for patient care shows up in the details — the follow-up call that catches something small before it becomes something serious, and the care plan that reflects a patient’s real life, not just their chart. Patients trust her, and that trust is what makes CIPRA’s Chronic Care Management program work.
She brings a decade of nursing experience and a track record of clinical leadership to the role. Her background spans hands-on patient care as an Endoscopy Nurse and Vascular Nurse, through progressively senior leadership roles including Nursing Manager at HCA Healthcare and Larkin Community Hospital South Miami, and Director of Nursing at Larkin Community Hospital. She brings that same operational and clinical rigor to how she leads CIPRA’s care team.
Ashton-Kara Shaw, LPN
Licensed Practical Nurse · Lead Remote Patient Monitoring Nurse
Ashton-Kara makes remote care feel personal. She is passionate about improving patient outcomes and about telephonic and virtual nursing done well — the steady, attentive follow-through that helps patients feel supported between visits.
Ashton-Kara brings more than five years of nursing experience, much of it in remote and telephonic care. She has specialized in remote patient monitoring, managing device alerts and supporting patients with at-home devices, and went on to supervise an RPM team — building daily assignments and schedules, tracking team metrics, and serving as the go-to resource for RPM questions. Her background in chart auditing, utilization management, quality control and HEDIS nursing gives her a strong command of clinical time tracking, documentation and billing requirements, while years of hands-on work at care facilities and virtual patient assessments keep her grounded in what patients need. That combination of clinical, operational and virtual-care experience is exactly what she brings to leading CIPRA’s RPM nursing team.
Clinical guidance
Physician Advisors
Dr. Holly Faber Tse, MD, FACP, FAAP
Chief Medical Advisor, Value-Based Care
Holly Faber Tse, MD, FACP, FAAP is a physician executive and healthcare strategist with 20 years of experience leading clinical quality, value-based care, and digital health transformation across integrated health systems. She currently serves as Regional Medical Director for the Pacific Northwest at Aledade, overseeing ACO clinical strategy and performance improvement across 90+ primary care practices in seven states. She is also the founder and CEO of Novella Insights, an executive advisory practice focused on healthcare quality and clinical transformation. Through Novella Insights, she leads “Clinic of the Future”–a redesign of outpatient care using AI and digital tools to replace clinic visits with a continuous, personalized flow of care for every patient. Previously, she served as Vice President and Hospital Chief Medical Officer at Legacy Mount Hood Medical Center, where she led enterprise quality strategy, medical staff governance, and Lean transformation. Board-certified in both Internal Medicine and Pediatrics, and still practicing and teaching, Dr. Tse brings deep expertise in population health strategy and health system operations to her role as Chief Medical Advisor, Value-Based Care at CIPRA.ai.
Dr. Christopher Thomas
Regional Quality Advisor, Kaiser Permanente Mid-Atlantic
Dr. Thomas has always been interested in the “big picture” — how healthcare systems intersect with business and healthcare policy to deliver high-quality care to patients. Throughout medical training and over seven years with Kaiser Permanente, this interest has been a consistent focus. As Physician Site Lead at Reston Medical Center, Dr. Thomas has ensured smooth operations and an excellent patient experience. In the role of Regional Quality Advisor, Dr. Thomas has developed and implemented numerous workflows across the healthcare system to improve the quality of care patients receive.
Dr. Katie Ryder
Co-Chief, Adult & Family Medicine, Kaiser Permanente Mid-Atlantic
Born and raised in the Washington, DC area, Dr. Ryder graduated from Tulane University School of Medicine in 2009 and completed residency training at the University of Chicago. Board-certified in both Internal Medicine and Pediatrics, Dr. Ryder provides primary care for adults and children at Kaiser Permanente and leads a team of 200 Adult & Family Medicine physicians and leaders across DC and Suburban Maryland.
Dr. Akhil Shenoy
Physician Director, Columbia University Medical Center
Akhil Shenoy MD MPH is an associate professor of psychiatry and director of transplant psychiatry at Columbia University Medical Center in NYC. He specializes in the psychiatric clinical care of liver and kidney transplant recipients and their donors. His research at Columbia includes alcohol use disorder and other addictions in the context of alcohol-associated liver disease, decision making in living organ donors and psychosocial outcomes after solid organ transplant. He completed undergraduate studies in biochemistry at UC San Diego, medical training at the Chicago Medical School, and residency and fellowship at Boston University Medical Center and Brigham and Women’s Hospital / Harvard Medical School.
Dr. Satya Toram
MD Managing Director, Blossom Ridge Medical Group
Dr. Satya Toram is a board-certified internal medicine and post-acute long-term care physician based in Saratoga, California. He co-owns Blossom Ridge Medical Group and serves as a medical director at a local nursing home. Dr. Toram has an extensive background in medicine, having worked in both the United Kingdom and the United States. He relocated to New York in 2005 for his residency at Unity Health System, affiliated with the University of Rochester. Following his residency, he practiced in Michigan and California. Passionate about the intersection of technology and medicine, Dr. Toram is particularly interested in electronic medical records, artificial intelligence, and remote patient monitoring.
Dr. Bhaskar Rajakumar
Program Director, Healthcare, ARTPARK
Dr. Bhaskar Rajakumar is a physician and healthcare innovator specializing in radiology and healthcare technology. With an MD, MBA, and advanced studies in public policy and strategy from IIM, he has over 15 years of experience across clinical care, healthcare administration, public policy, medical affairs, and healthcare technology. He is the Director of Healthcare Initiatives at ARTPARK (AI & Robotics Technology Park) at the Indian Institute of Science (IISc). He is an adjunct professor at Rajiv Gandhi University of Medical Sciences and PGIMER, and previously headed the COVID-19 War Room at BBMP. As founder of Mediknit, he pioneered technology-driven healthcare education for over a million healthcare professionals.
Connect with our team.
Company Info
Contact us
Our team members are located in San Diego, CA, Bay Area, CA, New York, NY, and Bengaluru, IN. We are available Monday through Friday, from 8am–5pm PST and IST. Reach out at any time and we will be happy to answer your questions. Or use the form on this page to send us a message.
Our Email
Meet Our Team
We'll introduce you to our amazing team members to learn more about us. Meet the team →
Send us a message
News & Events
In the News
Recent events we have attended, news, publications and awards for CIPRA.ai.
Techstars Healthcare Accelerator powered by Permanente Medicine — Mid-Atlantic States, Class of 2025
Sep 23, 2025
Read Article →
Escondido Times-Advocate features CIPRA.ai
Feb 18, 2025
Read Article →
AI-Based Health Coaching Aids Blood Pressure Management
Jun 12, 2024
Read Article →
CIPRA.ai launches personalized health services in India
Feb 5, 2024
Read Article →
Wellness Tech Platform CIPRA.ai Expands Its Services To India
Feb 6, 2024
Read Article →
CIPRA.ai expands its services to India
Feb 8, 2024
Read Article →
Chronic Diseases Targeted with New AI Platform
Sep 13, 2023
Read Article →
7 AI-Powered Technologies You Should Know About
Aug 22, 2023
Read Article →
AIMed Global Summit
Jun 4, 2023
Read Article →CIPRA.ai LinkedIn Posts
Legal
Privacy Policy
Effective date: January 31, 2026
At CIPRA.ai, we take your privacy seriously. Please read this Privacy Policy to learn how we treat your personal data. By using or accessing our Services in any manner, you acknowledge that you accept the practices and policies outlined below, and you hereby consent that we will collect, use and share your information as described in this Privacy Policy.
What this Privacy Policy Covers
This Privacy Policy covers how we treat Personal Data that we gather when you access or use our Services. “Personal Data” means any information that identifies or relates to a particular individual and also includes information referred to as “personally identifiable information” or “personal information” under applicable data privacy laws, rules or regulations. This Privacy Policy does not cover the practices of companies we don’t own or control or people we don’t manage.
Categories of Personal Data We Collect
This chart details the categories of Personal Data that we collect and have collected over the past 12 months:
Categories of Sources of Personal Data
We collect Personal Data about you from the following categories of sources:
1. When you provide such information directly to us.
- When you create an account or use our interactive tools and Services.
- When you voluntarily provide information through the Services or through responses to surveys or questionnaires.
- When you send us an email or otherwise contact us.
2. When you use the Services and such information is collected automatically.
- We may analyze how you interact and engage with the Services.
- If you download our mobile application or use a location-enabled browser, we may receive information about your location and mobile device, as applicable.
- If you download and install certain applications and software we make available, we may receive and collect information transmitted from your computing device for the purpose of providing you the relevant Services, such as information regarding when you are logged on and available to receive updates or alert notices.
Vendors
- We may use providers to analyze how you interact and engage with the Services, or third parties may help us provide you with customer support.
Device Manufacturers
- We use health, motion, and tracking data provided by authorized devices and wearables made by third party device manufacturers, e.g., Omron Corporation; iHealth Labs Inc.; Fitbit, Inc.; Apple, Inc; and Garmin Ltd.
Our Commercial or Business Purposes for Collecting Personal Data
Providing, Customizing and Improving the Services
- Creating and managing your account or other user profiles.
- Providing you with the products, services or information you request, including personalized responses and prompts, if applicable.
- Meeting or fulfilling the reason you provided the information to us.
- Providing support and assistance for the Services.
- Improving the Services, including testing, research, training models, internal analytics and product development.
- Personalizing the Services, website content and communications based on your preferences.
- Doing fraud protection, security and debugging.
- Provide lifestyle recommendations based on your data.
- Carrying out other business purposes stated when collecting your Personal Data or as otherwise set forth in applicable data privacy laws, such as the California Consumer Privacy Act (the “CCPA”).
Marketing the Services
- Marketing and selling the Services.
Corresponding with You
- Responding to correspondence that we receive from you, contacting you when necessary or requested, and sending you information about CIPRA.ai or the Services.
- Sending emails and other communications according to your preferences or that display content that we think will interest you.
Meeting Legal Requirements and Enforcing Legal Terms
- Fulfilling our legal obligations under applicable law, regulation, court order or other legal process, such as preventing, detecting and investigating security incidents and potentially illegal or prohibited activities.
- Protecting the rights, property or safety of you, CIPRA.ai or another party.
- Enforcing any agreements with you.
- Responding to claims that any posting or other content violates third-party rights.
- Resolving disputes.
We will not collect additional categories of Personal Data or use the Personal Data we collected for materially different, unrelated or incompatible purposes without providing you notice.
How We Share Your Personal Data
We disclose your Personal Data to the categories of service providers and other parties listed in this section. Depending on state laws that may be applicable to you, some of these disclosures may constitute a “sale” of your Personal Data. For more information, please refer to the state-specific sections below.
Service Providers
These parties help us provide the Services or perform business functions on our behalf. They include:
- Hosting, technology and communication providers.
- Third party artificial intelligence providers.
Parties You Authorize, Access or Authenticate
- If you are enrolled in the Services through your third party health system or health care provider, they may receive your data.
- Third party device manufacturers that you authorize may receive your data for authentication and use of their cloud services and APIs that retrieve your activity or blood pressure data from said devices.
Restrictions on Sharing Mobile and SMS Data
No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. All other categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties.
Legal Obligations
We may share any Personal Data that we collect with third parties in conjunction with any of the activities set forth under “Meeting Legal Requirements and Enforcing Legal Terms” in the “Our Commercial or Business Purposes for Collecting Personal Data” section above.
Business Transfers
All of your Personal Data that we collect may be transferred to a third party if we undergo a merger, acquisition, bankruptcy or other transaction in which that third party assumes control of our business (in whole or in part). Should one of these events occur, we will make reasonable efforts to notify you before your information becomes subject to different privacy and security policies and practices.
Data that is Not Personal Data
We may create aggregated, de-identified or anonymized data from the Personal Data we collect, including by removing information that makes the data personally identifiable to a particular user. We may use such aggregated, de-identified or anonymized data and share it with third parties for our lawful business purposes, including to analyze, build and improve the Services and promote our business, provided that we will not share such data in a manner that could identify you.
Data Security and Retention
We seek to protect your Personal Data from unauthorized access, use and disclosure using appropriate physical, technical, organizational and administrative security measures based on the type of Personal Data and how we are processing that data. You should also help protect your data by appropriately selecting and protecting your password and/or other sign-on mechanism; limiting access to your computer or device and browser; and signing off after you have finished accessing your account. Although we work to protect the security of your account and other data that we hold in our records, please be aware that no method of transmitting data over the internet or storing data is completely secure. However, we will ensure that the risk is minimal, as follows:
Secure Data Synchronization: All data collected from the mobile apps are protected by the device manufacturers with encryption security. Data is made accessible to CIPRA.ai only by directly accessing the secure cloud services and APIs provided by third party device manufacturers you authorize.
Data Storage and Processing: All data transmission will occur via secure encrypted connections. Data is stored in CIPRA.ai’s secure infrastructure which is managed by trained CIPRA.ai staff. All data collected, accessed and managed solely for the purposes of delivering the Service. The infrastructure storing data will use strong password protection and is located behind a secure and maintained firewall.
Identifiable Information: All identifiable information collected from you will be stored in a list that links it to a CIPRA.ai identification number (ID) separate from your health data. Only IDs will be used for storing and accessing health data. Once the participant stops use of the Service all identifiable information for the participant will be destroyed.
We retain Personal Data about you for as long as you have an open account with us or as otherwise necessary to provide you with our Services. In some cases we retain Personal Data for longer, if doing so is necessary to comply with our legal obligations, resolve disputes or collect fees owed, or is otherwise permitted or required by applicable law, rule or regulation. We may further retain information in an anonymous or aggregated form where that information would not identify you personally.
Personal Data of Children
As noted in the Terms and Conditions, we do not knowingly collect or solicit Personal Data about children under 13 years of age; if you are a child under the age of 13, please do not attempt to register for or otherwise use the Services or send us any Personal Data. If we learn we have collected Personal Data from a child under 13 years of age, we will delete that information as quickly as possible. If you believe that a child under 13 years of age may have provided Personal Data to us, please contact us at support@cipra.ai.
California Resident Rights
If you are a California resident, you have the rights set forth in this section. Please see the “Exercising Your Rights” section below for instructions regarding how to exercise these rights. Please note that we may process Personal Data of our customers’ end users or employees in connection with our provision of certain services to our customers. If we are processing your Personal Data as a service provider, you should contact the entity that collected your Personal Data in the first instance to address your rights with respect to such data.
If there are any conflicts between this section and any other provision of this Privacy Policy and you are a California resident, the portion that is more protective of Personal Data shall control to the extent of such conflict. If you have any questions about this section or whether any of the following rights apply to you, please contact us at support@cipra.ai.
Access
You have the right to request certain information about our collection and use of your Personal Data over the past 12 months. In response, we will provide you with the following information:
- The categories of Personal Data that we have collected about you.
- The categories of sources from which that Personal Data was collected.
- The business or commercial purpose for collecting or selling your Personal Data.
- The categories of third parties with whom we have shared your Personal Data.
- The specific pieces of Personal Data that we have collected about you.
If we have disclosed your Personal Data to any third parties for a business purpose over the past 12 months, we will identify the categories of Personal Data shared with each category of third party recipient. If we have sold your Personal Data over the past 12 months, we will identify the categories of Personal Data sold to each category of third party recipient.
Deletion
You have the right to request that we delete the Personal Data that we have collected about you. Under the CCPA, this right is subject to certain exceptions: for example, we may need to retain your Personal Data to provide you with the Services or complete a transaction or other action you have requested. If your deletion request is subject to one of these exceptions, we may deny your deletion request.
Exercising Your Rights
To exercise the rights described above, you or your Authorized Agent (defined below) must send us a request that (1) provides sufficient information to allow us to verify that you are the person about whom we have collected Personal Data, which includes at least your registered email, phone number, and ZIP code; and (2) describes your request in sufficient detail to allow us to understand, evaluate and respond to it. Each request that meets both of these criteria will be considered a “Valid Request.” We may not respond to requests that do not meet these criteria. We will only use Personal Data provided in a Valid Request to verify your identity and complete your request. You do not need an account to submit a Valid Request.
We will work to respond to your Valid Request within 45 days of receipt. We will not charge you a fee for making a Valid Request unless your Valid Request(s) is excessive, repetitive or manifestly unfounded. If we determine that your Valid Request warrants a fee, we will notify you of the fee and explain that decision before completing your request.
You may submit a Valid Request by emailing us at: support@cipra.ai.
You may also authorize an agent (an “Authorized Agent”) to exercise your rights on your behalf. To do this, you must provide your Authorized Agent with written permission to exercise your rights on your behalf, and we may request a copy of this written permission from your Authorized Agent when they make a request on your behalf.
Personal Data Sales Opt-Out and Opt-In
We will not sell your Personal Data, and have not done so over the last 12 months. To our knowledge, we do not sell the Personal Data of minors under 16 years of age.
We will not discriminate against you for exercising your rights under the CCPA. We will not deny you our goods or services, charge you different prices or rates, or provide you a lower quality of goods and services if you exercise your rights under the CCPA. However, we may offer different tiers of our Services as allowed by applicable data privacy laws (including the CCPA) with varying levels of quality of the services you receive related to the Personal Data that we receive from you.
California Resident Rights (Shine the Light)
Under California Civil Code Sections 1798.83-1798.84, California residents are entitled to contact us to prevent disclosure of Personal Data to third parties for such third parties’ direct marketing purposes; in order to submit such a request, please contact us at support@cipra.ai.
Your browser may offer you a “Do Not Track” option, which allows you to signal to operators of websites and web applications and services that you do not wish such operators to track certain of your online activities over time and across different websites. Our Services do not support Do Not Track requests at this time. To find out more about “Do Not Track,” you can visit www.allaboutdnt.com.
Nevada Resident Rights
If you are a resident of Nevada, you have the right to opt-out of the sale of certain Personal Data to third parties who intend to license or sell that Personal Data. You can exercise this right by contacting us at support@cipra.ai with the subject line “Nevada Do Not Sell Request” and providing us with your name and the email address associated with your account. For the avoidance of doubt, CIPRA.ai does not sell Personal Data.
Changes to this Privacy Policy
We’re constantly trying to improve our Services, so we may need to change this Privacy Policy from time to time, but we will alert you to any such changes by placing a notice on the CIPRA.ai website, by sending you an email and/or by some other means. Please note that if you’ve opted not to receive legal notice emails from us (or you haven’t provided us with your email address), those legal notices will still govern your use of the Services, and you are still responsible for reading and understanding them. If you use the Services after any changes to the Privacy Policy have been posted, that means you agree to all of the changes. Use of information we collect is subject to the Privacy Policy in effect at the time such information is collected.
Contact Information
If you have any questions or comments about this Privacy Policy, the ways in which we collect and use your Personal Data or your choices and rights regarding such collection and use, please do not hesitate to contact us at:
Legal
Terms & Conditions
Effective date: January 31, 2026
Welcome to the CIPRA.ai Hypertension and/or Diabetes management program (the “Service” or “Services”). The Service is owned by CIPRA.ai, Inc. and its subsidiaries or affiliates involved in providing and supporting the Service (collectively, “we,” “us,” “our,” or “CIPRA.ai”). Please read on to learn the rules and restrictions that govern your use of our website(s), products, and applications for the Service. By accessing or using the Service, including our websites or mobile applications in any way, you agree to be bound by these terms and conditions (the “Agreement”). If you have any questions, comments, or concerns regarding this Agreement or the Service, please contact us at:
Email: support@cipra.ai
Phone: +1 (619) 789-6089
Please read this Agreement and any referenced terms, such as our Privacy Policy, carefully. The Agreement includes information about future changes to this Agreement, limitations of liability, a class action waiver and resolution of disputes by arbitration instead of in court. PLEASE NOTE THAT YOUR USE OF AND ACCESS TO OUR SERVICE IS SUBJECT TO THIS AGREEMENT; IF YOU DO NOT AGREE TO ALL OF THE FOLLOWING, YOU MAY NOT USE OR ACCESS THE SERVICE IN ANY MANNER.
ARBITRATION NOTICE AND CLASS ACTION WAIVER: EXCEPT FOR CERTAIN TYPES OF DISPUTES DESCRIBED IN THE ARBITRATION AGREEMENT SECTION BELOW, YOU AGREE THAT DISPUTES BETWEEN YOU AND US WILL BE RESOLVED BY BINDING, INDIVIDUAL ARBITRATION AND YOU WAIVE YOUR RIGHT TO PARTICIPATE IN A CLASS ACTION LAWSUIT OR CLASS-WIDE ARBITRATION.
1. Scope of Service
This Agreement is a binding contract between you and CIPRA.ai, and applies to your use of the Service. We have other websites and services that may be covered by different terms of use.
The Service provides a variety of content, products and services, including personal activity and blood pressure/glucose monitoring, data analysis, participant access to a personal CIPRA.ai account, personalized recommendations for improving blood pressure/glucose, access to CIPRA.ai’s mobile and web-based hypertension and/or diabetes management systems, and technologies, including AI Services (defined below), and on call, monitoring, support features, and information provided by CIPRA.ai’s staff.
The Service may include or rely on certain artificial intelligence or machine learning modules (“AI Services”). The AI Services may include certain functionalities that are made available through the integration of any deep learning, and other artificial intelligence systems provided by third-party AI providers (“Third Party AI Provider”). You can request information identifying CIPRA.ai’s current Third Party AI Providers by sending an email to support@cipra.ai. Any User Submissions (defined below) you submit to the AI Services may be recorded to provide, maintain, and improve the Services.
In order to use the Service, you may use a supported activity tracker and Bluetooth-enabled blood pressure/glucose monitor, e.g., activity trackers made by Fitbit, Inc. or Apple, Inc., and blood pressure/glucose monitors made by Omron Corporation or iHealth Labs Inc. Your use of such activity trackers and blood pressure/glucose monitors with the Service is additionally subject to any applicable terms of use and privacy policy from each device’s manufacturer.
Features and specifications of products or services described or depicted on the Service are subject to change at any time without notice.
You may be required to sign up for an account, select a password and user name (“User ID”), and provide us with certain information or data, such as your contact information. You promise to provide us with accurate, complete, and updated registration information about yourself. You may not select as your User ID a name that you do not have the right to use, or another person’s name with the intent to impersonate that person. You may not transfer your account to anyone else without our prior written permission.
You represent and warrant that you are an individual of legal age to form a binding contract (or if not, you’ve received your parent’s or guardian’s permission to use the Service and have gotten your parent or guardian to agree to this Agreement on your behalf).
You will only use the Service for your own internal, personal, non-commercial use, and not on behalf of or for the benefit of any third party, and only in a manner that complies with all laws that apply to you. If your use of the Service is prohibited by applicable laws, then you aren’t authorized to use the Services. We can’t and won’t be responsible for your using the Service in a way that breaks the law.
You will not share your User ID, account or password with anyone, and you must protect the security of your User ID, account, password and any other access tools or credentials. You’re responsible for any activity associated with your User ID and account.
2. No Medical Advice; Not for Emergencies
CIPRA.ai does not offer medical advice or diagnoses, or engage in the practice of medicine. Our Service is not intended to be a substitute for professional medical advice, diagnosis, or treatment and are offered for informational and communicative purposes only. The Service is not intended to be, and must not be taken to be, the practice of medicine, nursing, pharmacy or other healthcare advice by CIPRA.ai.
The Service is not meant to diagnose or treat any conditions – only your medical professional can determine the right course of treatment for you and determine what is safe, appropriate and effective based on your needs. Reliance on any information provided by CIPRA.ai or in connection with the Service is solely at your own risk. You are solely responsible for any decisions or actions you take based on the information and materials available through the Service.
You acknowledge that although some Content (defined below) may be provided by individuals in the medical profession, the provision of such Content does not create a medical professional/patient relationship between you and CIPRA.ai or between you and any other individual or entity, and does not constitute an opinion, medical advice, or diagnosis or treatment. Healthcare providers and patients should always obtain applicable diagnostic information from appropriate trusted sources. Healthcare providers should never withhold professional medical advice or delay in providing it because of something they have read in connection with our Services.
THE SERVICES SHOULD NEVER BE USED AS A SUBSTITUTE FOR EMERGENCY CARE. IF YOU HAVE A MEDICAL OR MENTAL HEALTH EMERGENCY, ARE THINKING ABOUT SUICIDE OR TAKING ACTIONS THAT MAY CAUSE HARM TO YOU OR TO OTHERS, YOU SHOULD SEEK EMERGENCY TREATMENT AT THE NEAREST EMERGENCY ROOM OR DIAL 911.
3. Data Privacy
CIPRA.ai takes the privacy of its users very seriously. For the current CIPRA.ai Privacy Policy, please visit: www.cipra.ai/privacy-policy/.
Children’s Online Privacy Protection Act. The Children’s Online Privacy Protection Act (“COPPA”) requires that online service providers obtain parental consent before they knowingly collect personally identifiable information online from children who are under 13 years of age. We do not knowingly collect or solicit personally identifiable information from children under 13 years of age; if you are a child under 13 years of age, please do not attempt to register for or otherwise use the Service or send us any personal information. If we learn we have collected personal information from a child under 13 years of age, we will delete that information as quickly as possible. If you believe that a child under 13 years of age may have provided us personal information, please contact us at support@cipra.ai.
4. Right to Change This Agreement
We are constantly trying to improve our Service, so this Agreement may need to change along with our Service. We reserve the right to change the Agreement at any time, but if we do, we will place a notice on our site located at https://www.cipra.ai/, send you an email, and/or notify you by some other means.
If you don’t agree with the new Agreement, you are free to reject it; unfortunately, that means you will no longer be able to use the Service. If you use the Service in any way after a change to the Agreement is effective, that means you agree to all of the changes.
Except for changes by us as described here, no other amendment or modification of this Agreement will be effective unless in writing and signed by both you and us.
5. SMS Messaging and Communications
As part of the Service, you may receive communications, including messages that CIPRA.ai sends you (for example, via email or SMS). SMS messages may include, for example, data collection reminders or lifestyle recommendations. To stop the SMS text service at any time, text STOP to (844) 914-1333. By signing up for the Service and providing us with your wireless number, you confirm that you want CIPRA.ai to send you information regarding your account or transactions with us, which may include CIPRA.ai using automated dialing technology to text you at the wireless number you provided, and you agree to receive communications from CIPRA.ai, and you represent and warrant that each person you register for the Services or for whom you provide a wireless phone number has consented to receive communications from CIPRA.ai. You agree to indemnify and hold CIPRA.ai harmless from and against any and all claims, liabilities, damages (actual and consequential), losses and expenses (including attorneys’ fees) arising from or in any way related to your breach of the foregoing.
6. Rights in the Service
The materials displayed or performed or available on or through the Service, including, but not limited to, text, graphics, data, articles, photos, images, illustrations and so forth (all of the foregoing, the “Content”) are protected by copyright and/or other intellectual property laws. You promise to abide by all copyright notices, trademark rules, information, and restrictions contained in any Content you access through the Service, and you won’t use, copy, reproduce, modify, translate, publish, broadcast, transmit, distribute, perform, upload, display, license, sell, commercialize or otherwise exploit for any purpose any Content not owned by you, (i) without the prior consent of the owner of that Content or (ii) in a way that violates someone else’s (including CIPRA.ai’s) rights.
Subject to this Agreement, we grant each user of the Service a worldwide, non-exclusive, non-sublicensable and non-transferable license to use (i.e., to download and display locally) Content solely for purposes of using the Service. Use, reproduction, modification, distribution or storage of any Content for any purpose other than using the Service is expressly prohibited without prior written permission from us. You understand that CIPRA.ai owns the Service. You won’t modify, publish, transmit, participate in the transfer or sale of, reproduce (except as expressly provided in this section), create derivative works based on, or otherwise exploit any of the Service. The Service may allow you to copy or download certain Content, but please remember that even where these functionalities exist, all the restrictions in this section still apply.
Anything you post, upload, share, store, or otherwise provide through the Services is your “User Submission”. You are solely responsible for all User Submissions you contribute to the Services, including that all User Submissions submitted by you are in compliance with all applicable laws, rules and regulations. For all User Submissions, you hereby grant CIPRA.ai a royalty-free, perpetual, sublicensable, irrevocable, and worldwide license to translate, modify (for technical purposes, for example, making sure your content is viewable on a mobile device as well as a computer) and reproduce and otherwise act with respect to such User Submissions, in each case to enable us to operate, maintain, and improve the Services. This is a license only – your ownership in User Submissions is not affected. Please note that the foregoing license is subject to our Privacy Policy to the extent they relate to User Submissions that are also your personally-identifiable information.
7. Terminating Use of the Service
You are free to terminate your use of the Service at any time by contacting us at support@cipra.ai. CIPRA.ai is also free to terminate (or suspend access to) your use of the Service or your account for any reason in our discretion, including your breach of this Agreement. CIPRA.ai has the sole right to decide whether you are in violation of any of the restrictions set forth in this Agreement.
Account termination may result in destruction of any Content associated with your account, so keep that in mind before you decide to terminate your account.
Provisions that, by their nature, should survive termination of this Agreement shall survive termination. By way of example, all of the following will survive termination: any obligation you have to indemnify us, any limitations on our liability, any terms regarding ownership or intellectual property rights, and terms regarding disputes between us, including without limitation the arbitration agreement.
8. Mobile Applications
You acknowledge and agree that the availability of our mobile application is dependent on the third party stores from which you download the application, e.g., the App Store from Apple or the Android app market from Google (each an “App Store”). Each App Store may have its own terms and conditions to which you must agree before downloading mobile applications from such store, including the specific terms relating to Apple App Store set forth below. You agree to comply with, and your license to use our application is conditioned upon your compliance with, such App Store terms and conditions. To the extent such other terms and conditions from such App Store are less restrictive than, or otherwise conflict with, the terms and conditions of this Agreement, the more restrictive or conflicting terms and conditions in this Agreement apply.
Apple App Store: This Agreement applies to your use of the Service, including our iOS applications (the “Application”) available via the Apple, Inc. (“Apple”) App Store, but the following additional terms also apply to the Application:
- Both you and CIPRA.ai acknowledge that the Agreement is concluded between you and CIPRA.ai only, and not with Apple, and that Apple is not responsible for the Application or the Content;
- The Application is licensed to you on a limited, non-exclusive, non-transferrable, non-sublicensable basis, solely to be used in connection with the Service for your private, personal, non-commercial use, subject to all the terms and conditions of this Agreement as they are applicable to the Service;
- You will only use the Application in connection with an Apple device that you own or control;
- You acknowledge and agree that Apple has no obligation whatsoever to furnish any maintenance and support services with respect to the Application;
- In the event of any failure of the Application to conform to any applicable warranty, including those implied by law, you may notify Apple of such failure; upon notification, Apple’s sole warranty obligation to you will be to refund to you the purchase price, if any, of the Application;
- You acknowledge and agree that CIPRA.ai, and not Apple, is responsible for addressing any claims you or any third party may have in relation to the Application;
- You acknowledge and agree that, in the event of any third-party claim that the Application or your possession and use of the Application infringes that third party’s intellectual property rights, CIPRA.ai, and not Apple, will be responsible for the investigation, defense, settlement and discharge of any such infringement claim;
- You represent and warrant that you are not located in a country subject to a U.S. Government embargo, or that has been designated by the U.S. Government as a “terrorist supporting” country, and that you are not listed on any U.S. Government list of prohibited or restricted parties;
- Both you and CIPRA.ai acknowledge and agree that, in your use of the Application, you will comply with any applicable third-party terms of agreement which may affect or be affected by such use; and
- Both you and CIPRA.ai acknowledge and agree that Apple and Apple’s subsidiaries are third-party beneficiaries of this Agreement, and that upon your acceptance of this Agreement, Apple will have the right (and will be deemed to have accepted the right) to enforce this Agreement against you as the third-party beneficiary hereof.
9. General Terms
Use Restrictions: You represent, warrant, and agree that you will not provide or contribute anything, including any Content, to the Service, or otherwise use or interact with the Service, in a manner that: (a) infringes or violates the intellectual property rights or any other rights of anyone else (including CIPRA.ai); (b) violates any law or regulation, including, without limitation, any applicable export control laws, privacy laws or any other purpose not reasonably intended by CIPRA.ai; (c) is dangerous, harmful, fraudulent, deceptive, threatening, harassing, defamatory, obscene, or otherwise objectionable; (d) jeopardizes the security of your User ID, account or anyone else’s (such as allowing someone else to log in to the Service as you); (e) attempts, in any manner, to obtain the password, account, or other security information from any other user; (f) violates the security of any computer network, or cracks any passwords or security encryption codes; (g) runs Maillist, Listserv, any form of auto-responder or “spam” on the Service, or any processes that run or are activated while you are not logged into the Service, or that otherwise interfere with the proper working of the Service (including by placing an unreasonable load on the Service’s infrastructure); (h) “crawls,” “scrapes,” or “spiders” any page, data, or portion of or relating to the Service or Content (through use of manual or automated means); (i) copies or stores any significant portion of the Content; or (j) decompiles, reverse engineers, or otherwise attempts to obtain the source code or underlying ideas or information of or relating to the Service. A violation of any of the foregoing is grounds for termination of your right to use or access the Service.
Warranty Disclaimer: CIPRA.ai and its licensors, suppliers, partners, parent, subsidiaries or affiliated entities, and each of their respective officers, directors, members, employees, consultants, contract employees, representatives and agents, and each of their respective successors and assigns (CIPRA.ai and all such parties together, the “CIPRA.ai Parties”) make no representations or warranties concerning the Service, including without limitation regarding any Content contained in or accessed through the Service, and the CIPRA.ai Parties will not be responsible or liable for the accuracy, copyright compliance, legality, or decency of material contained in or accessed through the Service or any claims, actions, suits procedures, costs, expenses, damages or liabilities arising out of use of, or in any way related to your participation in, the Service. The CIPRA.ai Parties make no representations or warranties regarding suggestions or recommendations of services or products offered or purchased through or in connection with the Service. THE SERVICE AND CONTENT ARE PROVIDED BY CIPRA.AI (AND ITS LICENSORS AND SUPPLIERS) ON AN “AS-IS” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, OR THAT USE OF THE SERVICES WILL BE UNINTERRUPTED OR ERROR-FREE. SOME STATES DO NOT ALLOW LIMITATIONS ON HOW LONG AN IMPLIED WARRANTY LASTS, SO THE ABOVE LIMITATIONS MAY NOT APPLY TO YOU.
Limitation of Liability: TO THE FULLEST EXTENT ALLOWED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES AND UNDER NO LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, TORT, CONTRACT, STRICT LIABILITY, OR OTHERWISE) SHALL ANY OF THE CIPRA.AI PARTIES BE LIABLE TO YOU OR TO ANY OTHER PERSON FOR (A) ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR LOST PROFITS, BUSINESS INTERRUPTION, LOSS OF DATA, LOSS OF GOODWILL, WORK STOPPAGE, ACCURACY OF RESULTS, OR COMPUTER FAILURE OR MALFUNCTION, (B) ANY SUBSTITUTE GOODS, SERVICES OR TECHNOLOGY, (C) ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF ONE-HUNDRED ($100) DOLLARS OR (D) ANY MATTER BEYOND OUR REASONABLE CONTROL. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
Indemnity: To the fullest extent allowed by applicable law, you agree to indemnify and hold the CIPRA.ai Parties harmless from and against any and all claims, liabilities, damages (actual and consequential), losses and expenses (including attorneys’ fees) arising from or in any way related to any claims relating to (a) your use of the Service (including any actions taken by a third party using your account), and (b) your violation of this Agreement. In the event of such a claim, suit, or action (“Claim”), we will attempt to provide notice of the Claim to the contact information we have for your account (provided that failure to deliver such notice shall not eliminate or reduce your indemnification obligations hereunder).
Assignment: You may not assign, delegate or transfer this Agreement or your rights or obligations hereunder, or your Service account, in any way (by operation of law or otherwise) without CIPRA.ai’s prior written consent. We may transfer, assign, or delegate this Agreement and our rights and obligations without consent.
Choice of Law: This Agreement is governed by and will be construed under the Federal Arbitration Act, applicable federal law, and the laws of the State of California, without regard to the conflicts of laws provisions thereof.
Arbitration Agreement: Please read the following ARBITRATION AGREEMENT carefully because it requires you to arbitrate certain disputes and claims with CIPRA.ai and limits the manner in which you can seek relief from CIPRA.ai. Both you and CIPRA.ai acknowledge and agree that for the purposes of any dispute arising out of or relating to the subject matter of this Agreement, CIPRA.ai’s officers, directors, employees and independent contractors (“Personnel”) are third-party beneficiaries of this Agreement, and that upon your acceptance of this Agreement, Personnel will have the right (and will be deemed to have accepted the right) to enforce this Agreement against you as the third-party beneficiary hereof.
- (a) Arbitration Rules; Applicability of Arbitration Agreement. The parties shall use their best efforts to settle any dispute, claim, question, or disagreement arising out of or relating to the subject matter of this Agreement directly through good-faith negotiations, which shall be a precondition to either party initiating arbitration. If such negotiations do not resolve the dispute, it shall be finally settled by binding arbitration in San Diego County, California. The arbitration will proceed in the English language, in accordance with the JAMS Streamlined Arbitration Rules and Procedures then in effect, by one commercial arbitrator with substantial experience in resolving commercial contract disputes. The arbitrator shall be selected from the appropriate list of JAMS arbitrators in accordance with such Rules. Judgment upon the award rendered by such arbitrator may be entered in any court of competent jurisdiction.
- (b) Costs of Arbitration. The Rules will govern payment of all arbitration fees. CIPRA.ai will pay all arbitration fees for claims less than seventy-five thousand ($75,000) dollars. CIPRA.ai will not seek its attorneys’ fees and costs in arbitration unless the arbitrator determines that your claim is frivolous.
- (c) Small Claims Court; Infringement. Either you or CIPRA.ai may assert claims, if they qualify, in small claims court in San Diego County, California or any United States county where you live or work. Furthermore, notwithstanding the foregoing obligation to arbitrate disputes, each party shall have the right to pursue injunctive or other equitable relief at any time, from any court of competent jurisdiction, to prevent the actual or threatened infringement, misappropriation or violation of a party’s copyrights, trademarks, trade secrets, patents or other intellectual property rights.
- (d) Waiver of Jury Trial. YOU AND CIPRA.AI WAIVE ANY CONSTITUTIONAL AND STATUTORY RIGHTS TO GO TO COURT AND HAVE A TRIAL IN FRONT OF A JUDGE OR JURY. You and CIPRA.ai are instead choosing to have claims and disputes resolved by arbitration. Arbitration procedures are typically more limited, more efficient, and less costly than rules applicable in court and are subject to very limited review by a court. In any litigation between you and CIPRA.ai over whether to vacate or enforce an arbitration award, YOU AND CIPRA.AI WAIVE ALL RIGHTS TO A JURY TRIAL, and elect instead to have the dispute be resolved by a judge.
- (e) Waiver of Class or Consolidated Actions. ALL CLAIMS AND DISPUTES WITHIN THE SCOPE OF THIS ARBITRATION AGREEMENT MUST BE ARBITRATED OR LITIGATED ON AN INDIVIDUAL BASIS AND NOT ON A CLASS BASIS. CLAIMS OF MORE THAN ONE CUSTOMER OR USER CANNOT BE ARBITRATED OR LITIGATED JOINTLY OR CONSOLIDATED WITH THOSE OF ANY OTHER CUSTOMER OR USER. If however, this waiver of class or consolidated actions is deemed invalid or unenforceable, neither you nor CIPRA.ai is entitled to arbitration; instead all claims and disputes will be resolved in a court as set forth in (g) below.
- (f) Opt-out. You have the right to opt out of the provisions of this Section by sending written notice of your decision to opt out to the following address: 4458 Philbrook Square, San Diego, CA 92130, postmarked within thirty (30) days of first accepting this Agreement. You must include (i) your name and residence address, (ii) the email address and/or telephone number associated with your account, and (iii) a clear statement that you want to opt out of this Agreement’s arbitration agreement.
- (g) Exclusive Venue. If you send the opt-out notice in (f), and/or in any circumstances where the foregoing arbitration agreement permits either you or CIPRA.ai to litigate any dispute arising out of or relating to the subject matter of this Agreement in court, then the foregoing arbitration agreement will not apply to either party, and both you and CIPRA.ai agree that any judicial proceeding (other than small claims actions) will be brought in the state or federal courts located in, respectively, San Diego County, California, or the federal district in which that county falls.
- (h) Severability. If the prohibition against class actions and other claims brought on behalf of third parties contained above is found to be unenforceable, then all of the preceding language in this Arbitration Agreement section will be null and void. This arbitration agreement will survive the termination of your relationship with CIPRA.ai.
Miscellaneous
The failure of either you or us to exercise, in any way, any right herein shall not be deemed a waiver of any further rights hereunder. If any provision of this Agreement is found to be unenforceable or invalid, that provision will be limited or eliminated, to the minimum extent necessary, so that this Agreement shall otherwise remain in full force and effect and enforceable. If you have not signed a separate written agreement with CIPRA.ai related to the Service, you and CIPRA.ai agree that this Agreement is the complete and exclusive statement of the mutual understanding between you and CIPRA.ai, and that this Agreement supersedes and cancels all previous written and oral agreements, communications and other understandings relating to the subject matter of this Agreement. You hereby acknowledge and agree that you are not an employee, agent, partner, or joint venture of CIPRA.ai, and you do not have any authority of any kind to bind CIPRA.ai in any respect whatsoever.
Except as expressly set forth in the sections above regarding the Apple Application and the arbitration agreement, you and CIPRA.ai agree there are no third-party beneficiaries intended under this Agreement.